Published in Vaccine Weekly, August 16th, 1999
The technique works by simultaneously stimulating the body's natural immune response and dampening a mechanism that normally protects the body from attack by its own immune cells.
"This two-pronged approach not only kills tumors in mice, but it also produces a characteristic response that we see in the few humans with aggressive melanoma who survive the disease, whether through therapy or spontaneous remission," said James Allison, a Howard Hughes Medical Institute investigator at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1999-08-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.